Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant
Open Access
- 26 May 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Hepatitis Reports
- Vol. 11 (2), 82-89
- https://doi.org/10.1007/s11901-012-0130-x
Abstract
Women of childbearing age with recognized hepatitis B infection should have their liver disease assessed before pregnancy occurs since the management of hepatitis B virus (HBV) infection in this setting is complex. Initiation of treatment in a woman of child-bearing age will depend on when she intends on conceiving, as well as the severity of her liver disease. During pregnancy, all decisions about initiating, continuing or stopping HBV therapy must include an analysis of the risks and benefits for both mother and fetus. The trimester of the pregnancy and the stage of the mother’s liver disease are important factors. Treatment in the third trimester may be considered to aid in prevention of perinatal transmission, which appears to be most pronounced in mothers with high viral loads. Consideration of initiation of third trimester treatment should occur after a high viral load is documented in the latter part of the second trimester, to allow adequate time for initiation of antiviral therapy with significant viral suppression before delivery. This discussion should include the topic of breastfeeding, since it is generally not recommended while on antiviral therapy. Until recently lamivudine and tenofovir appeared to be the therapeutic options with the most reasonable safety data in pregnancy. There are emerging data that telbivudine may also be considered in this setting.Keywords
This publication has 43 references indexed in Scilit:
- 736 LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCEJournal of Hepatology, 2011
- A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virusWorld Journal of Gastroenterology, 2011
- Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B VirusObstetrics & Gynecology, 2010
- Prevalence of hepatitis B virus DNA polymerase mutations in treatment‐naïve patients with chronic hepatitis BAlimentary Pharmacology & Therapeutics, 2009
- Chronic hepatitis B: Update 2009Hepatology, 2009
- HEPATOLOGY: A home for hepatocellular cancer publicationsHepatology, 2009
- Exacerbation of chronic hepatitis B infection after deliveryJournal of Viral Hepatitis, 2007
- Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriersObstetrics & Gynecology, 2002
- Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier StateThe Journal of Infectious Diseases, 1985
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983